Search

Your search keyword '"Messina, Nicole L."' showing total 44 results

Search Constraints

Start Over You searched for: Author "Messina, Nicole L." Remove constraint Author: "Messina, Nicole L." Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
44 results on '"Messina, Nicole L."'

Search Results

2. Accelerated Bacille Calmette-Guérin reactions: More than meets the eye

3. Bacille Calmette-Guérin vaccination to prevent febrile and respiratory illness in adults (BRACE): secondary outcomes of a randomised controlled phase 3 trial

7. Specific and off-target immune responses following COVID-19 vaccination with ChAdOx1-S and BNT162b2 vaccines—an exploratory sub-study of the BRACE trial

8. Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trial

9. Bacille Calmette-Guérin vaccination to prevent febrile and respiratory illness in adults (BRACE): secondary outcomes of a randomised controlled phase 3 trial

10. No evidence of durable trained immunity after two doses of adenovirus-vectored or mRNA COVID-19 vaccines

11. Factors influencing scar formation following Bacille Calmette-Guérin (BCG) vaccination

12. A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines

13. Factors influencing adverse events following COVID-19 vaccination

15. Neonatal BCG Vaccination for Prevention of Allergy in Infants: The MIS BAIR Randomised Controlled Trial.

16. Inappropriate prescribing contributes to high antibiotic exposure in young children in Australia.

19. Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trial

22. Safety of BCG vaccination and revaccination in healthcare workers

23. Impact of vaccine platform and BCG vaccination on antibody responses to COVID-19 vaccination

25. Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers

27. A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA (BNT162b2/mRNA-1273) and adenovirus vectored vaccines (ChAdOx1-S) after the first, second and third doses

28. Neonatal BCG vaccination is associated with a long-term DNA methylation signature in circulating monocytes

30. Bacillus Calmette-Guérin Skin Reaction Predicts Enhanced Mycobacteria-Specific T-Cell Responses in Infants: APost HocAnalysis of a Randomized Controlled Trial

31. Hepatitis B vaccine co-administration influences the heterologous effects of neonatal BCG vaccination in a sex-differential manner

32. BCG vaccination to reduce the impact of COVID-19 in healthcare workers: Protocol for a randomised controlled trial (BRACE trial)

34. Prevention of infant eczema by neonatal Bacillus Calmette‐Guérin vaccination: The MIS BAIR randomized controlled trial

35. Off‐target effects of bacillus Calmette–Guérin vaccination on immune responses to SARS‐CoV‐2: implications for protection against severe COVID‐19.

36. Bacillus Calmette-Guérin Skin Reaction Predicts Enhanced Mycobacteria-Specific T-Cell Responses in Infants: A Analysis of a Randomized Controlled Trial.

37. Prevention of infant eczema by neonatal Bacillus Calmette‐Guérin vaccination: The MIS BAIR randomized controlled trial.

38. Neonatal Bacille Calmette-Guérin Vaccination and Infections in the First Year of Life: The MIS BAIR Randomized Controlled Trial.

39. THE AUTHORS REPLY.

40. BCG vaccination of healthcare workers for protection against COVID-19: 12-month outcomes from an international randomised controlled trial.

41. Specific and off-target immune responses following COVID-19 vaccination with ChAdOx1-S and BNT162b2 vaccines-an exploratory sub-study of the BRACE trial.

44. Bacillus Calmette-Guérin Skin Reaction Predicts Enhanced Mycobacteria-Specific T-Cell Responses in Infants: A Post Hoc Analysis of a Randomized Controlled Trial.

Catalog

Books, media, physical & digital resources